Physician profile
John Jansen
NPI 1154855054
$1,160.91
in general payments reported to CMS, 2019-2025
13 companies · $238 in 2025
The $238 reported for 2025 was more than what 78% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $40.59 · 2021: $264 · 2022: $170 · 2023: $192 · 2024: $257 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $686.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $521.26 | 2021-2025 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $123.41 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $117.36 | 2021-2025 | Vaxelis, Gardasil 9, Rotateq |
| Pfizer INC. | $113.01 | 2022-2025 | |
| Tris Pharma INC | $65.83 | 2020-2021 | |
| Seqirus USA INC | $61.44 | 2024 | Flucelvax |
| Cranial Technologies, INC | $32.59 | 2024-2025 | Doc Band |
| Ironshore Pharmaceuticals INC. | $31.16 | 2020-2022 | |
| Neurelis, INC. | $29.21 | 2021 | |
| Sanofi Pasteur INC. | $21.38 | 2023 | |
| Sanofi-Aventis U.S. LLC | $17.75 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $15.32 | 2021 | |
| Glaxosmithkline, LLC. | $11.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Jansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.